Low FAT4 expression was found to be significantly associated with stage, race, sex, age, weight, grade, TP53 mutation status, and tumor histology in patients with HCC (Table S3 in the Supplementary Material). This evidence concerns the gene FAT4 and hepatocellular carcinoma.